See All Slides -

Slides

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

Presenter: Eugenio Stabile

October 23, 2012

Presentation TCT 2012

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

DESyneBD (Elixir Medical) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Pro!

Presenter: Tony Das

October 23, 2012

Presentation TCT 2012

Utilizing Technology to Geographically Expand Your Practice

Presenter: Santosh Venkatesha

October 23, 2012

Presentation TCT 2012

Didactic Overview(5)

Presenter: Regina Deible

October 23, 2012

Presentation TCT 2012

Supply Chain Management: Lowering Costs and Utilization

Presenter: Michael Guiry

October 23, 2012

Presentation TCT 2012

Few Patients with Functional MR are Treated Surgically: Duke Database Results

Presenter: Mitchell Krucoff

October 23, 2012

Advertisement

Slides

How to Become Trained and Start a LAA Closure Program

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

DESyneBD (Elixir Medical) Program Update

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Pro!

Utilizing Technology to Geographically Expand Your Practice

Didactic Overview(5)

Supply Chain Management: Lowering Costs and Utilization

Few Patients with Functional MR are Treated Surgically: Duke Database Results

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content